# FDA Inspection 1269423 - QPharma, Inc. - May 06, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/qpharma-inc/351c91d3-ec64-42c1-8a0c-224741102d9b
Source feed: FDA_Inspections

> FDA Inspection 1269423 for QPharma, Inc. on May 06, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269423
- Company Name: QPharma, Inc.
- Inspection Date: 2025-05-06
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1269423 - 2025-05-06](https://www.globalkeysolutions.net/records/fda_inspections/qpharma-inc/ee02e8d0-6aac-443f-9045-e1e31f7dc47b)
- [FDA Inspection 1032424 - 2017-09-26](https://www.globalkeysolutions.net/records/fda_inspections/qpharma-inc/b7302857-2ed1-4d5d-b419-d766f676f677)

Company: https://www.globalkeysolutions.net/companies/qpharma-inc/18824fe0-4341-47ca-b9cb-81a3e265506c

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d